tert-butylhydroperoxide has been researched along with azilsartan in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, H; Mao, P; Wang, J; Wang, T; Xie, CH | 1 |
1 other study(ies) available for tert-butylhydroperoxide and azilsartan
| Article | Year |
|---|---|
Azilsartan, an angiotensin II type 1 receptor blocker, attenuates tert-butyl hydroperoxide-induced endothelial cell injury through inhibition of mitochondrial dysfunction and anti-inflammatory activity.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Inflammatory Agents; Benzimidazoles; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Endothelial Cells; Mice; Mice, Inbred C57BL; Mitochondria; Oxadiazoles; Oxidative Stress; tert-Butylhydroperoxide | 2016 |